BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9

• Press Releases

  Genmab to Present at the 44th Annual J.P. Morgan Healthcare Conference

  January 5, 2026

   · 

  3 min read
• Press Releases

  Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

  January 5, 2026

   · 

  1 min read
• Press Releases

  SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a Disease-modifying Therapy for Parkinson’s Disease

  January 5, 2026

   · 

  6 min read
• Press Releases

  Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism

  January 5, 2026

   · 

  6 min read
• Press Releases

  Permanent J Code for ZUSDURI™ Now in Effect, Expanding Patient Access to Innovative Bladder Cancer Therapy

  January 5, 2026

   · 

  9 min read
• Press Releases

  Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

  January 5, 2026

   · 

  9 min read
• Press Releases

  Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations

  January 5, 2026

   · 

  7 min read
• Press Releases

  Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models

  January 5, 2026

   · 

  9 min read
• Press Releases

  Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution

  January 5, 2026

   · 

  6 min read
• Press Releases

  Compass Therapeutics Announces Key Leadership Appointments

  January 5, 2026

   · 

  5 min read